In this study, we screened different databases, including TCGA and Cbioporta, and identified one lncRNA, LINC00244, which could potentially negatively regulate PD-L1 expression and predict good clinical outcomes in HCC. This evidence concerns the gene CD274 and hepatocellular carcinoma.